Angiotensin 2 [aapp, bacs, phsu]
Antagonist [ortf]
Paroxysmal atrial fibrillation [dsyn]
Trial [resa]
Antiarrhythmic Drugs [phsu]
Safety [hcpp]
effects [qlco]
Receptor, Angiotensin II [aapp, rcpt]
Blockade [ftcn]
Patients [podg]
Structural [spco]
Heart disease [dsyn]
Well [qlco]
Established [qlco]
Efficacy [qlco]
PREVENT [phsu]
Atrial Fibrillation [patf]
Patients [podg]
Structural [spco]
Heart disease [dsyn]
Report [inpr]
Primary [qlco]
Of [spco]
Angiotensin 2 [aapp, bacs, phsu]
Antagonist [ortf]
Paroxysmal atrial fibrillation [dsyn]
Trial [resa]
investigated [ftcn]
Olmesartan medoxomil [orch, phsu]
Compared [acty]
placebo [topp]
Atrial Fibrillation [patf]
Burden [idcn]
Patients [podg]
Paroxysmal atrial fibrillation [dsyn]
Structural [spco]
Heart disease [dsyn]
Methods [inpr]
Antagonist [ortf]
Paroxysmal atrial fibrillation [dsyn]
Trial [resa]
prospective [resa]
randomized [resa]
placebo-controlled [resa]
Trial, Multicenter [resa]
Atrial Fibrillation [patf]
Burden [idcn]
Percentage [qnco]
days [tmco]
Documented [hlca]
Episodes [tmco]
Paroxysmal atrial fibrillation [dsyn]
Primary Endpoint [irda]
Study [mnob]
Patients [podg]
Documented [hlca]
Paroxysmal atrial fibrillation [dsyn]
Structural [spco]
Heart disease [dsyn]
randomized [resa]
placebo [topp]
mg% [qnco]
olmesartan [orch, phsu]
Concomitant Therapy [topp]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Antiarrhythmic Drugs [phsu]
prohibited [carb, imft, phsu]
Patients [podg]
Daily [tmco]
ECG NOS [diap]
symptoms [ftcn]
Intention [menp]
Trial [resa]
Patients [podg]
placebo [topp]
Group [idcn]
N NOS [aapp, imft]
olmesartan [orch, phsu]
Group [idcn]
N NOS [aapp, imft]
TELE [gngm]
ecgs [fndg]
Patients [podg]
placebo [topp]
Group [idcn]
ecgs [fndg]
olmesartan [orch, phsu]
Group [idcn]
ecgs [fndg]
TELE [gngm]
ecgs [fndg]
Record [inpr]
Primary Endpoint [irda]
Atrial Fibrillation [patf]
Burden [idcn]
Group [idcn]
P NOS [aapp, imft]
secondary [neop]
Parameters [fndg]
Including [ftcn]
Quality [qlco]
Life [idcn]
atrial fibrillation recurrent [dsyn]
Persistent atrial fibrillation [patf]
Hospitalizations [hlca]
Group [idcn]
Prescription [hlca]
Recovery [acty]
Medication [phsu]
Amiodarone [orch, phsu]
Parameter [spco]
Prescription [hlca]
Amiodarone [orch, phsu]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
0.022" [qnco]
Conclusions [idcn]
Receptor, Angiotensin II [aapp, rcpt]
Blockade [ftcn]
therapy [ftcn]
Atrial Fibrillation [patf]
Episodes [tmco]
Patients [podg]
Documented [hlca]
Paroxysmal atrial fibrillation [dsyn]
Structural [spco]
Heart disease [dsyn]
Clinical Trial [resa]
Registration [hlca]
URL [inpr]
HTTP [idcn]
WWW [mnob]
GOV [gngm]
Unique Identifier [inpr]
Circ [qnco]
